Type 2 diabetes drugs linked to heart failure

diab A clinical trial study, published in the Lancet Diabetes and Endocrinology, revealed that certain diabetic drugs are linked to . The study analyzed more than 95,000 patients from fourteen trials.

The data obtained from these patients was analyzed to calculate the relative risks of posed by each treatment methodology. The results reflect that there was a 14% increased risk of in patients who where on sugar lowering drugs to manage diabetes.

affects approximately 5.1 million people in the US and is characterized by breathlessness, tiredness and swollen ankles.

The researchers attributed the increased risk of directly to the type of diabetes therapy that was chosen, with some drugs more likely to cause than others, compared with placebo or standard care. In general it was revealed that for every kilo of weight gain due to sugar-lowering diabetes treatment, there was an associated 7% higher risk of directly linked to that treatment. For every 200 patients treated, there was one extra for after an average follow-up of 4 years.


Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for : a meta-analysis of randomised controlled trials, Jacob A Udell, et al., Lancet Diabetes Endocrinol., doi:10.1016/S2213-8587(15)00044-3, published online 16 March 2015, abstract.

Be Sociable, Share!

    Leave a Reply

    Your email address will not be published. Required fields are marked *